Iridium to Develop Next-Generation Government Handset With General Dynamics
Feb 16, 2016 13:00 pm UTC| Business
MCLEAN, Va., Feb. 16, 2016 -- Iridium Communications Inc. (NASDAQ:IRDM) announced today a contract award from global aerospace and defense company General Dynamics, to provide its newest satellite handset, the Iridium...
Feb 16, 2016 13:00 pm UTC| Business
WIXOM, Mich., Feb. 16, 2016 -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and...
Paratek Pharmaceuticals, Inc. to Present at Two Upcoming Investor Conferences
Feb 16, 2016 13:00 pm UTC| Business
BOSTON, Feb. 16, 2016 -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) today announced that President and Chief Medical Officer, Evan Loh, MD, will participate in two upcoming investor conferences. Paratek is a...
Paratek Pharmaceuticals to Report Fourth Quarter 2015 Financial Results on February 23, 2016
Feb 16, 2016 13:00 pm UTC| Business
BOSTON, Feb. 16, 2016 -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, announced...
Feb 16, 2016 13:00 pm UTC| Business
BARCELONA, Spain and CAMBRIDGE, Mass., Feb. 16, 2016 -- Oryzon Genomics (ISIN Code: ES0167733015), a clinical stage biopharmaceutical company leveraging epigenetics to develop therapies in oncology and neurodegenerative...
iAPPS Listed in Info-Tech Research Group’s WEM Vendor Landscape
Feb 16, 2016 13:00 pm UTC| Business
BURLINGTON, Mass., Feb. 16, 2016 -- Bridgeline Digital, Inc. (NASDAQ:BLIN), The Digital Engagement Company™, announced today that the iAPPS Digital Marketing Platform was listed in Info-Tech Research Group’s recent...
Intra-Cellular Therapies to Present at the 2016 RBC Capital Markets’ Healthcare Conference
Feb 16, 2016 13:00 pm UTC| Business
NEW YORK, Feb. 16, 2016 -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system ("CNS") disorders, today announced that Sharon...